Make plans to join us in Minneapolis, Minnesota for the 2025 ACOG Annual Clinical & Scientific Meeting (ACSM) being held May 16–18. This is a must-attend event for those committed to providing exceptional obstetric and gynecologic care.
2025 ACOG Annual Clinical & Scientific Meeting: What You May Have Missed
From primary care management of heavy menstrual bleeding to postpartum depression screening, find out what you may have missed at ACOG 2025.
Women’s Health Takeaways for Primary Care: Expert Insights from ACOG 2025
Hear experts' takeaways from ACOG 2025 on menopause care, postpartum depression screening, and obesity management.
Bringing PPD Screening to the Forefront of Maternal Health: A Q&A with Joy Baker, MD
ACOG 2025: Joy Baker, MD, discusses the urgent need to prioritize postpartum depression screening, normalize mental health in prenatal care, and strengthen continuity between OB-GYN and primary care.
Provider Gaps in Postpartum Depression Screening and Management Highlighted in New Study
ACOG 2025: Laxmi Gannu, MS, discusses key findings from a provider survey on postpartum depression screening practices, training gaps, and referral patterns.
Tailoring Weight Management Conversations Across a Woman’s Lifespan
Johanna Finkle, MD, outlines how clinicians can adapt weight management counseling during key stages of a woman’s life, from preconception through menopause.
The Weekly Dose: How Medicaid Policies Impact Postpartum Depression Care
At ACOG 2025, Elizabeth Mollard, PhD, discussed her research on Medicaid PPD screening and coverage policies on PPD diagnosis.
From Screening to Support: How PCPs Can Tackle PPD
ACOG 2025: Joy Baker, MD, urged primary care clinicians to screen early, refer confidently, and help change the statistics on maternal mental health.
Johanna Finkle, MD, on Approaching Weight Loss Discussions with Reproductive-Aged Patients
ACOG 2025: Johanna Finkle, MD, shares strategies to start weight conversations with patients and build clinician confidence in counseling and treatment options.
PPD Screening, Medicaid Coverage, and Access to Care: A Q&A with Elizabeth Mollard, PhD
ACOG 2025: Elizabeth Mollard, PhD, discusses her research on how Medicaid policies influence postpartum depression screening rates.
“I’m Just Tired”: Listening for the Words Patients Actually Use
ACOG 2025: Joy Baker, MD, discusses the importance of listening closely to how patients describe postpartum distress—and to read between the lines.
Laxmi Gannu, MS, Explains a New Study of Clinician's Knowledge of Post Partum Depression
ACOG 2025: The Junonia study was designed to understand gaps in care for women with PPD using surveys of their clinicians and care coordinators.
Nanette Santoro, MD, Highlights Findings on Fezolinetant From Pooled Analysis of Phase 3 Skylight Development Program Trials
The nonhormonal neurokinin-3 receptor antagonist improved menopausal adiposity without appreciable impact on body weight or BMI, Santoro explained at 2025 ACOG meeting.
When We Talk About Perinatal Weight Issues, We Need to Focus on the Whole Person, Johanna Finkle, MD, Reminds Clinicians
ACOG 2025: Pregnant patients may not want to discuss weight gain initially, so focus on overall perinatal health, and use that information to guide more conversation.
Why Postpartum Depression Is Still Off the Radar in Pregnancy Care
LeThenia Joy Baker, MD, explains why PPD is often overlooked compared to physical pregnancy conditions like gestational diabetes.
Postpartum Inpatient HPV Vaccination Significantly Boosts Uptake at Urban Hospital, Study Finds
An intervention that included educational materials for clinicians on a multidisciplinary prenatal and postpartum care team helped drive acceptance.
Prenatal Substance Use Counseling: Missed Opportunities for Intervention
Pregnant patients' perceptions do not match clinician certainty on abstinence counseling during pregnancy, and clinicians may not be asking patients about their partner's substance use.
Study Reveals Major Gaps in Thyroid Screening During Pregnancy
Researchers report an alarming number of missed opportunities to screen pregnant individuals for thyroid disease, including among women with a history of the condition.
Joy Baker, MD: Understanding Patient Language in PPD Screening
ACOG 2025: Dr Baker shares how language can help create a trusting space for patients to speak openly about postpartum depression.
Postpartum Depression and the Missed Hand-Off to Primary Care
ACOG 2025: Joy Baker, MD, called for stronger cross-specialty collaboration to address maternal mental health after birth.
ACOG 2025: Steven Fleischman, MD, Inaugurated as 76th President, Urges New Fellows to Lead with Purpose
Steven Fleischman, MD, was inaugurated as ACOG’s 76th president, urging new fellows to lead with purpose and recognize their value in women’s health care.
Primary Care Falls Short in Managing Adolescent Heavy Menstrual Bleeding, Researchers Warn
Fewer than half of young girls who experienced heavy menstrual bleeding were given hormonal treatment and far fewer were referred to gynecology, authors reported.
GLP1-RAs Superior to Metformin for CVD Risk Reduction in Women with PCOS, Large Study Finds
The findings support the potential cardiovascular advantages of the GLP-1RA class in women with PCOS, a population already at increased cardiometabolic risk.
Study Identifies 6 Components of a Pregnancy Exercise Program that Reduce Risk of Poor Perinatal Outcomes
While exercise is beneficial during pregnancy and ACOG recommends 150 mins/week, this is the first study to examine benefits of specific regimen elements on their own.
Fezolinetant Demonstrates Reduced Waist Circumference, Body Roundness and Stable Weight and BMI in 52-Week Pooled Analysis of Phase 3 SKYLIGHT Trials
Postmenopausal women taking fezolinetant experienced positive changes in body fat distribution, increases in which are known to increase risks of cardiometabolic disease.
ACOG 2025: Poster Highlights for Primary Care
Details on 12 key abstracts with clinical relevance for primary care, from menopause management to PPD screening and HPV testing.
Elinzanetant Demonstrates Clinically Meaningful Reductions in Menopausal Vasomotor Symptoms, Meta-analysis Shows
Elinzanetant reduced VMS frequency and intensity, and improved sleep and quality of life, according to the meta-analysis to be presented at the ACOG 2025 meeting.
Normalizing Mental Health: A Vital Sign in Prenatal and Postpartum Care
The Role of Primary Care in Women's Health With Laurence Shields, MD
The two areas where primary care physicians can contribute to improving women's health, according to Laurence Shields, MD.
ACOG 2025 Refresh: Menopausal VMS Education in Primary Care
Building trust with patients early on will help them feel comfortable discussing their symptoms and treatment preferences, says JoAnn Pinkerton, MD.
ACOG opens 2025 Annual Clinical & Scientific Meeting, 'Powered by Purpose,' in Minneapolis